Multiple epiphyseal dysplasia type 5 (MED5) is a rare genetic disorder that affects the growth of bones in the body. It is caused by a mutation in the COMP gene, which is responsible for the production of cartilage in the body. Symptoms of MED5 include short stature, joint pain, and skeletal deformities. People with MED5 may also experience hearing loss, vision problems, and learning disabilities. Treatment for MED5 is focused on managing the symptoms and improving quality of life.

The symptoms of Multiple epiphyseal dysplasia type 5 (MED5) vary from person to person, but may include:

- Short stature
- Joint pain
- Joint stiffness
- Limited range of motion
- Delayed closure of the growth plates in the long bones
- Abnormal curvature of the spine (scoliosis)
- Abnormal curvature of the lower legs (genu valgum)
- Abnormal curvature of the feet (clubfoot)
- Abnormal shape of the hip joint (dysplastic hip)
- Abnormal shape of the shoulder joint (dysplastic shoulder)
- Abnormal shape of the elbow joint (dysplastic elbow)
- Abnormal shape of the knee joint (dysplastic knee)
- Abnormal shape of

Multiple epiphyseal dysplasia type 5 (MED5) is a rare genetic disorder caused by mutations in the COMP gene. This gene provides instructions for making a protein called cartilage oligomeric matrix protein (COMP). This protein is important for the development and maintenance of cartilage, which is a type of connective tissue that forms the skeleton during early development and helps maintain joint function. Mutations in the COMP gene lead to the production of an abnormal COMP protein, which disrupts the development and maintenance of cartilage, resulting in the signs and symptoms of MED5.

The treatments for Multiple epiphyseal dysplasia type 5 (MED5) vary depending on the severity of the condition and the individual's symptoms. Generally, treatment focuses on managing the symptoms and preventing further joint damage. This may include physical therapy, occupational therapy, and bracing to help maintain joint stability and mobility. Surgery may be recommended to correct joint deformities or to replace damaged joints. Pain medications may also be prescribed to help manage pain. In some cases, growth hormone therapy may be recommended to help improve growth and development.

1. Genetic mutation: Multiple epiphyseal dysplasia type 5 is caused by a mutation in the COMP gene.

2. Family history: Multiple epiphyseal dysplasia type 5 is inherited in an autosomal dominant pattern, which means that a single copy of the mutated gene is enough to cause the disorder.

3. Age: Multiple epiphyseal dysplasia type 5 is usually diagnosed in childhood or adolescence.

There is no cure for Multiple epiphyseal dysplasia type 5 (MED5). Treatment focuses on managing the symptoms and preventing complications. This may include physical therapy, medications to reduce pain and inflammation, and surgery to correct joint deformities.